EntrestoBySylvester O. Agbahiwe PharmD, BCACP,Oluchi Juliet Emelogu, PharmD CandidateNovember 12th 2015Entresto is a combination of a first-in-class neprilysin inhibitor and an angiotensin receptor blocker indicated for the treatment of heart failure with reduced ejection fraction.